FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreACR® formally urged Robert F. Kennedy Jr., Secretary of the U.S. Department of Health and Human Services (HHS), to initiate a national public health awareness campaign promoting annual lung cancer screening for individuals at high risk of developing the disease.
In a recent comment letter, the College presented updated data that highlights the life-saving potential of lung cancer screening, cited emerging evidence that supports improved adherence to screening protocols, and expressed alignment with bipartisan legislation under consideration in Congress.
Despite coverage for lung cancer screening being available through Medicare and nearly all private insurers, public awareness of this critical preventive service remains alarmingly low. ACR asserts a targeted public health campaign — directed at both patients and healthcare providers — would significantly increase screening uptake and in turn improve outcomes for one of the nation’s deadliest cancers.
For further information regarding this advocacy initiative or Medicare coverage policies, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more